PolyPeptide Group AG (8H0)
FSX
Closed
Oct 2, 2026
Day's Range
46.4052 wk Range
23.40Overview - 8H0 - PolyPeptide Group AG
Key Statistics
Valuation
Enterprise Value
1.60B
P/E (Trailing)
‪105.45‬
Price / Sales (TTM)
‪3.33‬
Price / Book
‪4.36‬
EV / EBITDA
‪21.23‬
Profitability
Profit Margin
‪3.14%‬
Operating Margin
‪9.28%‬
Return on Assets
‪3.37%‬
Return on Equity
‪4.23%‬
Ownership
Shares Outstanding
33.01M
Float
12.96M
Held by Insiders
‪60.52%‬
Held by Institutions
‪13.24%‬
Price stats
Beta
‪1.00‬
50-Day Avg
‪46.41‬
200-Day Avg
‪38.29‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 8H0 - PolyPeptide Group AG
Peers - 8H0 - PolyPeptide Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - 8H0 - PolyPeptide Group AG
About
PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) focused on peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). Established with roots dating back to 1952 in Malmö, Sweden, it supports pharmaceutical and biotech companies by providing comprehensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
